89Bio Inc (ETNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ETNB | GLPG | MAZE | ||
| Company | 89Bio Inc | Galapagos NV ADR | Maze Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 14.83 | 33.58 | 44.50 | ||
| High | 14.87 | 34.15 | 46.13 | ||
| Low | 14.82 | 33.48 | 43.96 | ||
| Latest | 14.84 | 34.09 | 45.61 | ||
| Change | unch | +0.43 | +0.02 | ||
| % Change | unch | +1.28% | +0.04% | ||
| Volume | 55,645,300 | 75,700 | 236,600 | ||
| 20-Day Average Volume | 6,202,360 | 99,595 | 487,430 | ||
| Previous Close | 14.84 | 33.66 | 45.59 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 14.81 | 33.95 | 46.22 | ||
| 20-Day Raw Stochastic | 54.05% | 33.02% | 48.59% | ||
| 20-Day Relative Strength | 74.10 | 53.35 | 53.28 | ||
| Weighted Alpha | +10.94 | +26.82 | +178.30 | ||
| Today's Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.27% since 10/22/25 | +0.65% since 02/23/26 | +0.15% since 02/23/26 | ||
| Low | 14.78 on 10/24/25 | 33.03 on 02/26/26 | 43.96 on 03/02/26 | ||
| High | 14.87 on 10/29/25 | 36.24 on 02/24/26 | 47.49 on 02/25/26 | ||
| 1-Month | |||||
| %Chg | +0.95% since 09/29/25 | -0.41% since 02/02/26 | -1.98% since 02/02/26 | ||
| Low | 14.67 on 09/30/25 | 33.03 on 02/26/26 | 42.17 on 02/05/26 | ||
| High | 14.93 on 10/02/25 | 36.24 on 02/24/26 | 49.25 on 02/05/26 | ||
| 3-Month | |||||
| %Chg | +60.95% since 07/29/25 | +8.74% since 12/02/25 | +22.38% since 12/02/25 | ||
| Low | 7.84 on 09/15/25 | 30.73 on 12/16/25 | 37.37 on 01/06/26 | ||
| High | 15.06 on 09/18/25 | 36.24 on 02/24/26 | 49.25 on 02/05/26 | ||
| 6-Month | |||||
| %Chg | +96.56% since 04/29/25 | +9.40% since 09/02/25 | +197.72% since 09/02/25 | ||
| Low | 7.37 on 05/15/25 | 29.81 on 11/05/25 | 14.16 on 09/04/25 | ||
| High | 15.06 on 09/18/25 | 37.78 on 10/03/25 | 49.25 on 02/05/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,200,891 | 2,218,194 | 2,193,745 | ||
| Shares Outstanding, K | 148,308 | 65,900 | 48,119 | ||
| Annual Sales | 0 | 298,280,000 | 167,500,000 | ||
| Annual Net Income | -367,080,000 | 80,160,000 | 52,230,000 | ||
| Last Quarter Sales | 0 | 78,990,000 | 0 | ||
| Last Quarter Net Income | -111,500,000 | -161,610,000 | -30,090,000 | ||
| 60-Month Beta | 1.27 | 0.24 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.71 on 08/07/25 | -2.47 on 04/23/25 | -0.66 on 11/06/25 | ||
| Latest Earnings Date | 11/06/25 | 04/22/26 | 03/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||